AAAAAA
Results:
1-13
|
Results: 13
Authors:
JEWELL AP
WORMAN CP
GILES FJ
GOLDSTONE AH
Citation: Ap. Jewell et al., SERUM LEVELS OF TNF, IL-6 AND SCD23 CORRELATE WITH CHANGES IN LYMPHOCYTE COUNT IN PATIENTS WITH B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA RECEIVING INTERFERON-ALPHA THERAPY, Leukemia & lymphoma, 24(3-4), 1997, pp. 327-333
Authors:
JEWELL AP
LYDYARD PM
WORMAN CP
GILES FJ
GOLDSTONE AH
Citation: Ap. Jewell et al., GROWTH-FACTORS CAN PROTECT B-CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS AGAINST PROGRAMMED CELL-DEATH WITHOUT STIMULATING PROLIFERATION, Leukemia & lymphoma, 18(1-2), 1995, pp. 159-162
Authors:
TSAKONAS DP
NICOLAIDES KH
TSAKONA CP
WORMAN CP
GOLDSTONE AH
Citation: Dp. Tsakonas et al., CHANGES IN MATERNAL PLASMA MACROPHAGE-COLONY-STIMULATING FACTOR LEVELS DURING NORMAL-PREGNANCY, Clinical and laboratory haematology, 17(1), 1995, pp. 57-59
Authors:
WAGNER L
WIESHOLZER M
WORMAN CP
LANG G
BASE W
Citation: L. Wagner et al., BLT-ESTERASE IN INFECTIOUS-MONONUCLEOSIS, Clinical and experimental immunology, 100(2), 1995, pp. 223-226
Authors:
TSAKONAS DP
TSAKONA CP
WORMAN CP
GOLDSTONE AH
NICOLAIDES KH
Citation: Dp. Tsakonas et al., MYELOPEROXIDASE ACTIVITY AND NUCLEAR SEGMENTATION OF MATERNAL NEUTROPHILS DURING NORMAL-PREGNANCY, Clinical and laboratory haematology, 16(4), 1994, pp. 337-342
Authors:
JEWELL AP
WORMAN CP
LYDYARD PM
YONG KL
GILES FJ
GOLDSTONE AH
Citation: Ap. Jewell et al., INTERFERON-ALPHA UP-REGULATES BCL-2 EXPRESSION AND PROTECTS B-CLL CELLS FROM APOPTOSIS IN-VITRO AND IN-VIVO, British Journal of Haematology, 88(2), 1994, pp. 268-274
Authors:
JEWELL AP
YONG KL
WORMAN CP
TSAKONA CP
GILES FJ
GOLDSTONE AH
Citation: Ap. Jewell et al., SERUM MACROPHAGE-COLONY-STIMULATING FACTOR (M-CSF) LEVELS CORRELATE WITH CLINICAL-RESPONSE TO INTERFERON-ALPHA IN PATIENTS WITH EARLY-STAGEB-CLL, British Journal of Haematology, 86(2), 1994, pp. 441-443
Authors:
MCSWEENEY EN
GILES FJ
WORMAN CP
JEWEL AP
TSAKONA CP
HOFFBRAND AV
MEHTA AB
NEWLAND AC
CAWLEY JC
GALVANI D
SINGER CRJ
GRANT IR
NORFOLK DR
GOLDSTONE AH
Citation: En. Mcsweeney et al., RECOMBINANT INTERFERON-ALFA 2A IN THE TREATMENT OF PATIENTS WITH EARLY STAGE-B CHRONIC LYMPHOCYTIC-LEUKEMIA, British Journal of Haematology, 85(1), 1993, pp. 77-83
Authors:
TSAKONA CP
WORMAN CP
MCSWEENEY E
JEWELL A
GOLDSTONE AH
Citation: Cp. Tsakona et al., PLASMA M-CSF LEVELS IN AML AS A MARKER OF DISEASE-ACTIVITY AND RESPONSE TO TREATMENT WITH ALPHA-2A INTERFERON, British Journal of Haematology, 84, 1993, pp. 33-33
Authors:
MCSWEENEY EN
ADDISON IE
WORMAN CP
ISENBERG DA
GOLDSTONE AH
Citation: En. Mcsweeney et al., AUTOANTIBODY INDUCTION IN PATIENTS TREATED WITH RECOMBINANT ALPHA-INTERFERON, British Journal of Haematology, 84, 1993, pp. 45-45
Authors:
TSAKONA CP
MITSOU J
MCGROUTHER DA
CROWE R
GOLDSTONE AH
WORMAN CP
Citation: Cp. Tsakona et al., CD8-SPECIFIC SERINE ESTERASE ARE EFFECTORS OF REJECTION OF COMPLETELYMISMATCHED SKIN ALLOGRAFTS IN THE RAT( LYMPHOCYTES BEARING CYTOPLASMIC BLT), British Journal of Haematology, 84, 1993, pp. 54-54
Authors:
JEWELL AP
WORMAN CP
GILES FJ
LYDYARD PM
GOLDSTONE AH
Citation: Ap. Jewell et al., CYTOKINE REGULATION OF APOPTOSIS OF B-CLL CELLS IN-VITRO, Blood, 82(10), 1993, pp. 10000567-10000567
Authors:
MCSWEENEY EN
WORMAN CP
TSAKONA CP
JEWEL AP
HOFFBRAND AV
MILLIGAN DW
BURNETT AK
LEWIS ML
GOLDSTONE AH
Citation: En. Mcsweeney et al., LOW-DOSE RECOMBINANT ALPHA-2-A-INTERFERON - A FEASIBLE MAINTENANCE THERAPY IN ACUTE MYELOID-LEUKEMIA IN THE OLDER PATIENT, Acta haematologica, 89(1), 1993, pp. 1-5
Risultati:
1-13
|